Clinical trials
Phase 2 Heart Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 3 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardurion Pharmaceuticals, Inc. | 4 |
| Akcea Therapeutics | 1 |
| Cardiometabolics | 1 |
| Dr. Amer Johri | 1 |
| Eli Lilly and Company | 1 |
| KAI Pharmaceuticals | 1 |
| Kiniksa Pharmaceuticals International, plc | 1 |
| Mallinckrodt | 1 |
| Sanofi | 1 |
| The Hospital for Sick Children | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 13 |
| Cardiovascular Diseases | 7 |
| Heart Failure | 3 |
| Vascular Diseases | 2 |
| Atherosclerosis | 1 |
| Coronary Artery Disease | 1 |
| Dyslipidemias | 1 |
| Heart Defects, Congenital | 1 |
| Heart Failure, Diastolic | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.